Management of Metastatic Clear Cell Renal Cell Carcinoma: ASCO Guideline
2022 · Journal of Clinical Oncology · 301 citations
https://doi.org/10.1200/jco.22.00868
P
Peter J. Van Veldhuizen
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
157
Papers
5.6K
Citations
38
h-index
73
i10-index
Peter J. Van Veldhuizen is an academic researcher from Metro Health Hospital. The author has contributed to research in topics: Prostate Cancer Treatment and Research & Cancer Immunotherapy and Biomarkers & Prostate Cancer Diagnosis and Treatment. The author has an h-index of 38, co-authored 134 publications.
ORCID: 0000-0001-7140-4246Papers by this author
worksBoron Chemicals in Diagnosis and Therapeutics
2013 · Future Medicinal Chemistry · 268 citations
https://doi.org/10.4155/fmc.13.38
Overexpression of Her-2/Neu may be an Indicator of Poor Prognosis in Prostate Cancer
1993 · The Journal of Urology · 133 citations
https://doi.org/10.1016/s0022-5347(17)35413-7
Cyr61/CCN1 signaling is critical for epithelial-mesenchymal transition and stemness and promotes pancreatic carcinogenesis
2011 · Molecular Cancer · 114 citations
https://doi.org/10.1186/1476-4598-10-8
An in vitro cell irradiation protocol for testing photopharmaceuticals and the effect of blue, green, and red light on human cancer cell lines
2016 · Photochemical & Photobiological Sciences · 109 citations
https://doi.org/10.1039/c5pp00424a
2‐Methoxyestradiol modulates β‐catenin in prostate cancer cells: A possible mediator of 2‐methoxyestradiol‐induced inhibition of cell growth
2007 · International Journal of Cancer · 20 citations
https://doi.org/10.1002/ijc.23117
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat